Clinical trial No longer in our active list Observational Ages 18 and up

Assessing speech disorders in patients treated for oral or oropharyngeal cancer

Official title: Validity of a Task of Acoustic-phonetic Decoding on Anatomic Deficits in Paramedical Assessment of Speech Disorders for Patients Treated for Oral or Oropharyngeal Cancer

Run by University Hospital, Toulouse · NCT04742998 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing how well people who have been treated for oral or throat cancer can speak, using a special task to see if it helps understand their speech problems better.

More Speech Intelligibility trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment116 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Drugs / interventionschemotherapy
Locations3 sites (Marseille and 2 other locations)
Trial IDNCT04742998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include native French-speaking adults aged 18 and older who have been treated for oral or oropharyngeal cancer and are in clinical remission.

Probably not a fit

Patients with additional pathologies affecting speech or fluency disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate speech intelligibility in patients who have undergone treatment for oral or oropharyngeal cancer. It utilizes an acoustic-phonetic decoding task to objectively assess speech production and perception, bridging the gap between the two. The study hypothesizes that automatic processing of this task will provide reliable diagnostic insights into oropharyngeal deficits. Participants will be assessed based on their ability to produce isolated pseudo-words, with scores correlated to anatomical and functional speech deficits.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic tools for assessing speech disorders in cancer patients, enhancing their rehabilitation.

How similar studies have gone: While the approach is innovative, similar studies have shown promise in using objective measures for speech assessment in oncology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged at least 18 years old and benefiting from a social security scheme
* Native French-speaking patients
* Patients treated for cancer of the oral cavity or oropharynx (surgical and / or radiotherapy and / or chemotherapy treatment)
* Patients in clinical remission for at least 6 months (chronic nature and stability of the disorders)
* All tumor sizes according to the tumor (T), node (N), and metastasis (M) categories (TNM classification) (T1 to T4)
* Patients with a perceptible speech disorder in a conversational situation or not (to allow the determination of fine deficits)
* Patients who do not object to carrying out the research

Exclusion Criteria:

* Patients with an associated pathology potentially responsible for speech or fluency disorders (joint, speech and language disorders of developmental, organic or functional origin, voice disorders of organic or functional origin, stammering , stammering, fluency disturbances, speech disturbances of neurological origin)
* Patients reporting an auditory complaint and not having a hearing aid
* Inability to provide the person with enlightened information and to ensure the subject's compliance because of impaired physical and / or psychological health,
* Patients participating in another research including an exclusion period still in progress.

Where it's running

  • AP- H Marseille - Hôpital de la Conception
    Marseille, France
    Recruiting
  • University Hospital Toulouse
    Toulouse, France
    Recruiting
  • Institut universitaire du Cancer de Toulouse - Oncopole
    Toulouse, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.